Search Results 691-700 of 17006 for monoclonal antibody
Monoclonal antibodies, such as cetuximab, can interfere with tumor growth by blocking the ability of tumor cells to grow and spread. Tivantinib may stop the ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin ...
... Antibody ZL-1201 in Subjects with Advanced Cancer. Participation eligibility ... Previous exposure to any anti-CD-47 monoclonal antibody or SIRPα antibody.
Dinutuximab is a monoclonal antibody that binds to a molecule called GD2 ... Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways.
The purpose of this study is to measure SARS-CoV-2 Spike protein antibody titers in a vaccinated cohort. ... Receipt of any COVID-19-specific monoclonal ...
monoclonal antibody therapy (except for bone-modifying agents as supportive care), radiotherapy, or any other agents to treat cancer within 21 days ...
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody ... monoclonal antibody, or Interleukin-2 (IL-2) co ...
Other monoclonal antibodies, antibody-drug conjugates, or radioimmunoconjugates: 4 weeks (2 weeks with documented disease progression);; T-cell or other cell ...
Has had a prior monoclonal antibody within 4 weeks prior to study Day 1 or ... antibody (including ipilimumab or any other antibody or drug ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.